Discrepancy between the Actions of Glucagon-like Peptide-1 Receptor Ligands in the Protection of the Heart against Ischemia Reperfusion Injury

Discrepancy between the Actions of Glucagon-like Peptide-1 Receptor Ligands in the Protection of the Heart against Ischemia Reperfusion Injury

Tirzepatide is a dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist and a promising therapy for type 2 diabetes mellitus (T2DM). GLP-1 is an incretin hormone with therapeutic potential beyond type 2 diabetes mellitus. However, GLP-1 is rapidl...

Full description

Bibliographic Details
Main Authors: Ali Ismaeil, Fawzi Babiker, Suleiman Al-Sabah
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Pharmaceuticals
Subjects:
ischemia reperfusion
GLP-1
GLP-1 (9-36)
exendin-4
Online Access:https://www.mdpi.com/1424-8247/15/6/720

Internet

https://www.mdpi.com/1424-8247/15/6/720

Similar Items